A functional splice variant of the human Golgi CMP-sialic acid transporter

Glycoconjugate Journal

Volumn 33, Issue 6, 2016, Pages 897-906

  Salinas Marín, Roberta ^a   Mollicone, Rosella ^b   Martínez Duncker, Iván ^a  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^b Paris Sud 11 University   (France)

Author keywords

CDG; Lec 2; Morpholinos; Sialic acid; SLC35A1

Indexed keywords

AGGLUTININ; CARRIER PROTEIN; CYTIDINE 5' MONOPHOSPHO N ACETYLNEURAMINIC ACID; ISOPROTEIN; N ACETYLNEURAMINIC ACID DERIVATIVE; N AZIDOACETYL SIALIC ACID; PEANUT AGGLUTININ; RICINUS COMMUNIS AGGLUTININ I; SIALIC ACID; SIALIC ACID DERIVATIVE; TRANSPORTER SLC35A1 PROTEIN; UNCLASSIFIED DRUG; WHEAT GERM AGGLUTININ; NUCLEOTIDE TRANSPORTER; SLC35A1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CARBOHYDRATE TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; SIALYLATION; SLC35A1 GENE; SPLICE VARIANT; ALTERNATIVE RNA SPLICING; ANIMAL; BIOSYNTHESIS; CHO CELL LINE; CONGENITAL DISORDER OF GLYCOSYLATION; CRICETULUS; GENETICS; GOLGI COMPLEX; HEP-G2 CELL LINE; METABOLISM;

ALTERNATIVE SPLICING; ANIMALS; CHO CELLS; CONGENITAL DISORDERS OF GLYCOSYLATION; CRICETULUS; GOLGI APPARATUS; HEP G2 CELLS; HUMANS; NUCLEOTIDE TRANSPORT PROTEINS; PROTEIN ISOFORMS;

EID: 84978148910     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-016-9697-8     Document Type: Article

References (38)

1. Martinez-Duncker I., Mollicone R., Codogno P., Oriol R.: The nucleotide-sugar transporter family: a phylogenetic approach. Biochimie. 85(3–4), 245–260 (2003)
2. Handford M., Rodriguez-Furlan C., Orellana A.: Nucleotide-sugar transporters: structure, function and roles in vivo. Braz. J. Med. Biol. Res. 39(9), 1149–1158 (2006)
3. Eckhardt M., Gotza B., Gerardy-Schahn R.: Mutants of the CMP-sialic acid transporter causing the Lec2 phenotype. J. Biol. Chem. 273(32), 20189–20195 (1998)
4. Caffaro C.E., Hirschberg C.B.: Nucleotide sugar transporters of the Golgi apparatus: from basic science to diseases. Acc. Chem. Res. 39(11), 805–812 (2006)
5. Mironov, A. A.,Pavelka, M.: The Golgi apparatus: state of the art 110 years after Camillo Golgi’s discovery. Springer, Wien; New York (2008)
6. Furuichi T., Kayserili H., Hiraoka S., Nishimura G., Ohashi H., Alanay Y., Lerena J.C., Aslanger A.D., Koseki H., Cohn D.H., Superti-Furga A., Unger S., Ikegawa S.: Identification of loss-of-function mutations of SLC35D1 in patients with Schneckenbecken dysplasia, but not with other severe spondylodysplastic dysplasias group diseases. J. Med. Genet. 46(8), 562–568 (2009)
7. Hiraoka S., Furuichi T., Nishimura G., Shibata S., Yanagishita M., Rimoin D.L., Superti-Furga A., Nikkels P.G., Ogawa M., Katsuyama K., Toyoda H., Kinoshita-Toyoda A., Ishida N., Isono K., Sanai Y., Cohn D.H., Koseki H., Ikegawa S.: Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human. Nat. Med. 13(11), 1363–1367 (2007)
8. Mohamed M., Ashikov A., Guillard M., Robben J.H., Schmidt S., van den Heuvel B., de Brouwer A.P., Gerardy-Schahn R., Deen P.M., Wevers R.A., Lefeber D.J., Morava E.: Intellectual disability and bleeding diathesis due to deficient CMP–sialic acid transport. Neurology. 81(7), 681–687 (2013)
9. Jones C., Denecke J., Strater R., Stolting T., Schunicht Y., Zeuschner D., Klumperman J., Lefeber D.J., Spelten O., Zarbock A., Kelm S., Strenge K., Haslam S.M., Luhn K., Stahl D., Gentile L., Schreiter T., Hilgard P., Beck-Sickinger A.G., Marquardt T., Wild M.K.: A novel type of macrothrombocytopenia associated with a defect in alpha2,3-sialylation. Am. J. Pathol. 179(4), 1969–1977 (2011)
10. Willig T.B., Breton-Gorius J., Elbim C., Mignotte V., Kaplan C., Mollicone R., Pasquier C., Filipe A., Mielot F., Cartron J.P., Gougerot-Pocidalo M.A., Debili N., Guichard J., Dommergues J.P., Mohandas N., Tchernia G.: Macrothrombocytopenia with abnormal demarcation membranes in megakaryocytes and neutropenia with a complete lack of sialyl-Lewis-X antigen in leukocytes–a new syndrome? Blood. 97(3), 826–828 (2001)
11. Martinez-Duncker I., Dupre T., Piller V., Piller F., Candelier J.J., Trichet C., Tchernia G., Oriol R., Mollicone R.: Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. Blood. 105(7), 2671–2676 (2005)
12. Stanley P., Siminovitch L.: Complementation between mutants of CHO cells resistant to a variety of plant lectins. Somatic Cell Genet. 3(4), 391–405 (1977)
13. Riemersma M., Sandrock J., Boltje T.J., Bull C., Heise T., Ashikov A., Adema G.J., van Bokhoven H., Lefeber D.J.: Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal alpha-dystroglycan O-mannosylation, independent from sialic acid. Hum. Mol. Genet. 24(8), 2241–2246 (2015)
14. Eckhardt M., Muhlenhoff M., Bethe A., Gerardy-Schahn R.: Expression cloning of the Golgi CMP-sialic acid transporter. Proc. Natl. Acad. Sci. U. S. A. 93(15), 7572–7576 (1996)
15. Ishida N., Ito M., Yoshioka S., Sun-Wada G.H., Kawakita M.: Functional expression of human golgi CMP-sialic acid transporter in the Golgi complex of a transporter-deficient Chinese hamster ovary cell mutant. J. Biochem. 124(1), 171–178 (1998)
16. Shin D.J., Kang J.Y., Kim Y.U., Yoon J.S., Choy H.E., Maeda Y., Kinoshita T., Hong Y.: Isolation of new CHO cell mutants defective in CMP-sialic acid biosynthesis and transport. Mol Cells. 22(3), 343–352 (2006)
17. Briles E.B., Li E., Kornfeld S.: Isolation of wheat germ agglutinin-resistant clones of Chinese hamster ovary cells deficient in membrane sialic acid and galactose. J. Biol. Chem. 252(3), 1107–1116 (1977)
18. Parra M.K., Gee S., Mohandas N., Conboy J.G.: Efficient in vivo manipulation of alternative pre-mRNA splicing events using antisense morpholinos in mice. J. Biol. Chem. 286(8), 6033–6039 (2011)
19. Tyson-Capper A.J., Europe-Finner G.N.: Novel targeting of cyclooxygenase-2 (COX-2) pre-mRNA using antisense morpholino oligonucleotides directed to the 3′ acceptor and 5′ donor splice sites of exon 4: suppression of COX-2 activity in human amnion-derived WISH and myometrial cells. Mol. Pharmacol. 69(3), 796–804 (2006)
20. Chang P.V., Chen X., Smyrniotis C., Xenakis A., Hu T., Bertozzi C.R., Wu P.: Metabolic labeling of sialic acids in living animals with alkynyl sugars. Angew Chem Int Ed Engl. 48(22), 4030–4033 (2009)
21. Sharon N., Lis H.: Lectins, 2nd edn. Kluwer Academic Publishers, Boston (2003)
22. Patnaik S.K., Stanley P.: Lectin-resistant CHO glycosylation mutants. Methods Enzymol. 416, 159–182 (2006)
23. Erber W.N., Asbahr H., Meyer B., Herrmann R.P., Davies J.M.: Peanut agglutinin (lectin from Arachis hypogaea) binding to hemopoietic cells: an immunophenotypic study using a biotin streptavidin technique. Pathology. 24(3), 173–176 (1992)
24. Aoki K., Ishida N., Kawakita M.: Substrate recognition by UDP-galactose and CMP-sialic acid transporters. Different sets of transmembrane helices are utilized for the specific recognition of UDP-galactose and CMP-sialic acid. J Biol Chem. 276(24), 21555–21561 (2001)
25. Takeshima-Futagami T., Sakaguchi M., Uehara E., Aoki K., Ishida N., Sanai Y., Sugahara Y., Kawakita M.: Amino acid residues important for CMP-sialic acid recognition by the CMP-sialic acid transporter: analysis of the substrate specificity of UDP-galactose/CMP-sialic acid transporter chimeras. Glycobiology. 22(12), 1731–1740 (2012)
26. Maggioni A., von Itzstein M., Rodriguez Guzman I.B., Ashikov A., Stephens A.S., Haselhorst T., Tiralongo J.: Characterisation of CMP-sialic acid transporter substrate recognition. Chembiochem. 14(15), 1936–1942 (2013)
27. Beitz E. (2000) T(E)Xtopo: shaded membrane protein topology plots in LAT(E)X2epsilon. Bioinformatics. 16(11):1050-1051
28. Zhao W., Chen T.L., Vertel B.M., Colley K.J.: The CMP-sialic acid transporter is localized in the medial-trans Golgi and possesses two specific endoplasmic reticulum export motifs in its carboxyl-terminal cytoplasmic tail. J. Biol. Chem. 281(41), 31106–31118 (2006)
29. Tusnady G.E., Simon I.: The HMMTOP transmembrane topology prediction server. Bioinformatics. 17(9), 849–850 (2001)
30. Eckhardt M, Gotza B, Gerardy-Schahn R.: Membrane topology of the mammalian CMP-sialic acid transporter. J Biol Chem. 274(13), 8779–87 (1999)
31. Quiroga R., Trenchi A., Gonzalez Montoro A., Valdez Taubas J., Maccioni H.J.: Short transmembrane domains with high-volume exoplasmic halves determine retention of type II membrane proteins in the Golgi complex. J. Cell Sci. 126(Pt 23), 5344–5349 (2013)
32. Pasquier C., Promponas V.J., Palaios G.A., Hamodrakas J.S., Hamodrakas S.J.: A novel method for predicting transmembrane segments in proteins based on a statistical analysis of the SwissProt database: the PRED-TMR algorithm. Protein Eng. 12(5), 381–385 (1999)
33. Chan K.F., Zhang P., Song Z.: Identification of essential amino acid residues in the hydrophilic loop regions of the CMP-sialic acid transporter and UDP-galactose transporter. Glycobiology. 20(6), 689–701 (2010)
34. Aoki K., Ishida N., Kawakita M.: Substrate recognition by nucleotide sugar transporters: further characterization of substrate recognition regions by analyses of UDP-galactose/CMP-sialic acid transporter chimeras and biochemical analysis of the substrate specificity of parental and chimeric transporters. J. Biol. Chem. 278(25), 22887–22893 (2003)
35. Oelmann S., Stanley P., Gerardy-Schahn R.: Point mutations identified in Lec8 Chinese hamster ovary glycosylation mutants that inactivate both the UDP-galactose and CMP-sialic acid transporters. J. Biol. Chem. 276(28), 26291–26300 (2001)
36. Saini P., Gaur N.A., Prasad R.: Chimeras of the ABC drug transporter Cdr1p reveal functional indispensability of transmembrane domains and nucleotide-binding domains, but transmembrane segment 12 is replaceable with the corresponding homologous region of the non-drug transporter Cdr3p. Microbiology. 152(Pt 5), 1559–1573 (2006)
37. Lim S.F., Lee M.M., Zhang P., Song Z.: The Golgi CMP-sialic acid transporter: a new CHO mutant provides functional insights. Glycobiology. 18(11), 851–860 (2008)
38. Wang Q., Yin H., Camelliti P., Betts C., Moulton H., Lee H., Saleh A.F., Gait M.J., Wood M.J.: In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy. J Gene Med. 12(4), 354–364 (2010)